Diana Tait

11.2k total citations · 1 hit paper
187 papers, 7.6k citations indexed

About

Diana Tait is a scholar working on Oncology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Diana Tait has authored 187 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 81 papers in Surgery and 54 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Diana Tait's work include Colorectal Cancer Surgical Treatments (62 papers), Colorectal and Anal Carcinomas (53 papers) and Advanced Radiotherapy Techniques (31 papers). Diana Tait is often cited by papers focused on Colorectal Cancer Surgical Treatments (62 papers), Colorectal and Anal Carcinomas (53 papers) and Advanced Radiotherapy Techniques (31 papers). Diana Tait collaborates with scholars based in United Kingdom, Spain and Sweden. Diana Tait's co-authors include Gina Brown, David Cunningham, A. Norman, Ian Chau, David P. Dearnaley, Andrew Wotherspoon, John Yarnold, Vincent Khoo, Alan E. Nahum and Jervoise Andreyev and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Diana Tait

184 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1999 536 citations David P. Dearnaley, Vincent Khoo et al. The Lancet profile →

Peers

Countries citing papers authored by Diana Tait

Since Specialization

Citations

This map shows the geographic impact of Diana Tait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Tait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Tait more than expected).

Fields of papers citing papers by Diana Tait

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Tait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Tait. The network helps show where Diana Tait may publish in the future.

Co-authorship network of co-authors of Diana Tait

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Tait. A scholar is included among the top collaborators of Diana Tait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Tait. Diana Tait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma 2024 ·Cancers ·Kai Tai Derek Yeung, Joseph Doyle, Sacheen Kumar, K. Aitken, Diana Tait, David Cunningham, Long R. Jiao, Ricky H. Bhogal	0
2	Staged Celiac Artery Resection with Pancreatosplenectomy (SCARPS) - A Novel Approach to Pancreatic Cancer Encasing Celiac Axis Trunk Robotically 2023 ·Spiral (Imperial College London) ·Long R. Jiao, (unknown), Naureen Starling, Diana Tait, (unknown), (unknown), David Cunningham	1
3	Radiological Biomarkers in MRI directed Rectal Cancer Radiotherapy Volume Delineation 2023 ·Cancers ·Charleen Chan Wah Hak, Svetlana Balyasnikova, Samuel J. Withey, Diana Tait, Gina Brown, Irene Chong	1
4	Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer 2018 ·Annals of Oncology ·Shelize Khakoo, (unknown), Nicola Valeri, (unknown), Thomas R. Jones, Ruwaida Begum, Isma Rana, (unknown), Maria Antonietta Bali, Gina Brown, Andrew Wotherspoon, Monica Terlizzo, Katharina von Loga, Imtiaz Ahmed, David Watkins, Ian Chau, Naureen Starling, Diana Tait, Michael Hubank, David Cunningham	1
5	KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial 2016 ·Annals of Oncology ·Francesco Sclafani, Ian Chau, David Cunningham, (unknown), (unknown), Andrea Lampis, Chiara Braconi, (unknown), David González de Castro, Andrew Wotherspoon, Jaume Capdevila, (unknown), Andrés Cervantes, Ruwaida Begum, Hazel Lote, Giulia Mentrasti, Jens C. Hahne, Diana Tait, Gina Brown, Nicola Valeri	1
6	PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer 2016 ·Annals of Oncology ·Francesco Sclafani, Gina Brown, David Cunningham, Andrew Wotherspoon, Diana Tait, Clare Peckitt, Jessica Evans, Shun Yu, Larissa Mendes, Josep Tabernero, Bengt Glimelius, Andrés Cervantes, Janet Thomas, Ruwaida Begum, J. Oates, Ian Chau	54
7	Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C) 2012 ·Journal of Clinical Oncology ·Alice Dewdney, David Cunningham, Josep Tabernero, Jaume Capdevila, Bengt Glimelius, Andrés Cervantes, Diana Tait, Gina Brown, Andrew Wotherspoon, David González de Castro, Yu Jo Chua, Rachel Wong, Yolanda Barbáchano, J. Oates, Ian Chau	287
8	A Solitary Bone Lesion in a Patient With Previous Breast Cancer and the Importance of Bone Biopsy: A Case Report and a Review of Guidelines 2012 ·Clinical Breast Cancer ·Gaia Schiavon, Diana Tait, Tim Briggs, Ian E. Smith	2
9	Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies 2012 ·European Journal of Cancer ·Linda Wedlake, (unknown), Barbara Benton, Amyn Lalji, Karen Thomas, David P. Dearnaley, (unknown), Diana Tait, Vincent Khoo, Jervoise Andreyev	52
10	Set-up errors in radiotherapy for oesophageal cancers – Is electronic portal imaging or conebeam more accurate? 2010 ·Radiotherapy and Oncology ·M. Hawkins, (unknown), Vibeke N. Hansen, H. McNair, Diana Tait	37
11	Evaluating Mesorectal Lymph Nodes in Rectal Cancer Before and After Neoadjuvant Chemoradiation Using Thin-Section T2-Weighted Magnetic Resonance Imaging 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Dow‐Mu Koh, Ian Chau, Diana Tait, Andrew Wotherspoon, David Cunningham, Gina Brown	95
12	Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy 2007 ·British Journal of Cancer ·Asma Sultana, Catrin Tudur Smith, David Cunningham, Naureen Starling, Diana Tait, John P. Neoptolemos, Paula Ghaneh	162
13	MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: Treatment with radiotherapy and chemotherapy 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Sarah Burton, Gina Brown, I. R. Daniels, Andy Norman, Ian Swift, Muti Abulafi, A. Wotherspoon, Diana Tait	49
14	Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy 2005 ·Radiotherapy and Oncology ·Lone Gothard, Paul Cornes, (unknown), Judith Earl, J.P. Glees, Emma Hall, Clare Peckitt, Diana Tait, John Yarnold	41
15	Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? 2002 ·Bone Marrow Transplantation ·Jayesh Mehta, R Powles, Bhawna Sirohi, J Treleaven, S Kulkarni, Radovan Sašo, Diana Tait, Seema Singhal	32
16	Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial 2000 ·The Lancet ·R Powles, Jayesh Mehta, Samar Kulkarni, J Treleaven, Barbara C. Millar, (unknown), V Shepherd, A. J. Rowland, Bhawna Sirohi, Diana Tait, C Horton, S. G. Long, Seema Singhal	268
17	A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold? 2000 ·Bone Marrow Transplantation ·Seema Singhal, R Powles, J Treleaven, S Kulkarni, Bhawna Sirohi, C Horton, B. C. Millar, V Shepherd, Diana Tait, Radovan Sašo, A. J. Rowland, S. G. Long, Jayesh Mehta	85
18	Melphalan/TBI is not more carcinogenic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years 2000 ·Bone Marrow Transplantation ·S Kulkarni, R Powles, J Treleaven, Seema Singhal, C Horton, Bhawna Sirohi, (unknown), Diana Tait, Radovan Sašo, Sally Killick, Ross Pinkerton, Ayad Atra, S Meller, Minesh P. Mehta	17
19	Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). 1999 ·British Journal of Radiology ·(unknown), Diana Tait, Alan E. Nahum, S Webb	30
20	Second cancers after non-autologous bone marrow transplantation for hematologic malignancies 1998 ·British Journal of Haematology ·(unknown), R Powles, Seema Singhal, Minesh P. Mehta, J Treleaven, C Horton, (unknown), CR Pinkerton, Ayad Atra, Diana Tait	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact